Participated · Series A · May 2026

Resurrect Bio’s core product is its FloraFold AI platform, trained to predict protein–protein interactions between crops and pathogens, coupled with high-throughput in-silico and in-planta screening to validate candidates. The company identifies pathogen effectors that bind plant NLR immune proteins and recommends specific, often minimal, gene edits for partners to break those interactions and restore resistance. Resurrect Bio does not perform the gene edits itself but provides precise targets and instructions to seed companies and breeders. It has demonstrated proof points such as conferring resistance to potato cyst nematode and has a joint development agreement with Corteva to work on corn disease resistance. Founded in December 2021 as a spinout from The Sainsbury Laboratory in Norwich, the company has raised a total of $12.4M and will use the new capital to grow its team and advance development of disease-resistance traits.

Participated · Series C · Mar 2026

Tevel develops flying autonomous robots and drone harvesting systems that pick fruit without human intervention. Its technology is described as ‘Physical AI’ aimed at automating harvesting to alleviate labour shortages and improve supply‑chain efficiency. Tevel is already working with commercial fruit producers, including Unifrutti in Chile and HMC Farms in California. The company raised $18 million in a Series C to accelerate deployment of its systems. Tevel plans to scale its operations and expand deployments in orchards and plantations globally. The article did not disclose revenue, user counts, or a valuation.

Participated · Equity · Sep 2025

Founded in 2020, Scindo has built a proprietary, data-rich platform that combines experimentally validated reaction datasets with advanced AI models to discover, design and optimise novel enzymes. These enzymes catalyse the conversion of challenging, renewable feedstocks directly into bio-active ingredients, offering a sustainable alternative to petroleum-derived chemicals. The company positions its technology as a full-stack solution that enables consistent, scalable production of natural ingredients across multiple high-value sectors such as food, flavourings, cosmetics and specialty chemicals. Industry traction is already evident through partnerships with leading specialty chemical manufacturers and pilot-scale initiatives aimed at bringing the first products to market. Recent hiring from top pharmaceutical firms and the University of Oxford has strengthened expertise in machine learning, enzyme engineering, process scaling and commercialisation. Proceeds from the latest funding will expand the enzyme discovery engine, scale wet-lab capabilities and grow the team. The company did not disclose revenue or user metrics, but investor interest highlights strong demand for bio-based solutions that deliver both performance and sustainability.

Participated · Series A · Aug 2025

Singrow develops heat-tolerant strawberry varieties and applies genetics-first agri-tech to seed breeding, vertical farming and reverse genetics. The company operates a propagation facility in Guangzhou since 2023, supplying strawberries to China and exporting to Singapore, Indonesia and Thailand. Field trials are underway in Vietnam, Malaysia and other regional markets as it positions itself across Southeast Asia. Singrow is building one of the region’s largest indoor farms in Singapore to co-cultivate strawberries and white-button mushrooms using a circular farming model that reuses CO2 from mushroom production. A similar facility is planned for Houston, Texas, and additional projects are planned for Vietnam and China. The company intends to use new capital to deepen breeding and farming work and to expand into new markets, including planned entries into Saudi Arabia and Brunei.

Participated · Seed · May 2025

Uviquity develops solid-state far-UVC (200-230 nm) semiconductor light sources designed to provide safe, continuous, chemical-free disinfection for air, food, and water. Its core technology is a proprietary photonic integrated circuit that couples blue laser light into frequency-doubling waveguides to produce a scalable, single-chip far-UVC solution. The company says the chip can be made small enough to fit on the tip of a finger and to integrate into standard photonic packages for fixtures, air handling systems, food processing equipment, agricultural protection systems, water purification, and consumer appliances. Uviquity emerged from stealth with $6.6M in seed funding to accelerate R&D and productization of its platform. The company was founded in 2022 and is based in Raleigh, N.C. Uviquity positions its semiconductor approach as a more compact, energy-efficient, durable, and scalable alternative to bulky gas-discharge far-UVC lamps.